Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · DarioHealth Corp. (DRIO)

DarioHealth's President and Chief Commercial Officer Steven Nelson to leave company

Neutral Impact 4 of 5 leadership Written later

DarioHealth said President and Chief Commercial Officer Steven Nelson will stop serving in that role on September 1, 2026, and his employment ends September 30, 2026, under a separation agreement signed August 20, 2026. Nelson will then provide consulting services through December 31, 2027, for which the company plans to grant him 30,000 restricted shares, subject to Compensation Committee approval.

Key points

  • Nelson ceases as President and Chief Commercial Officer effective September 1, 2026; employment ends September 30, 2026.
  • Company will reimburse up to three months of COBRA health coverage at $2,600 per month after the separation date.
  • Consulting agreement effective October 1, 2026, runs through December 31, 2027, with a grant of 30,000 restricted shares, subject to Compensation Committee approval.

The filing

CompanyDarioHealth Corp. (DRIO)
Form8-K, current report
Filed with the SECAug 21, 2026, 4:05 PM ET
Accession number0001104659-26-099678

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.